Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Soy Protein Health Claim Measurement Alternative Proposed By FDA

This article was originally published in The Tan Sheet

Executive Summary

Compliance with the proposed health claim for soy protein and a reduced risk of coronary artery disease would be determined based upon the measurement of a product's total protein, FDA says in a revised proposed rule in the Aug. 23 Federal Register. Manufacturers would be required to produce documentation regarding the amount of soy protein in foods that also contain non-soy protein sources.

You may also be interested in...



Soy Protein Heart Health Claim History: Approved In 1999

Editor's note: Tan Sheet editors nearly 20 year ago reported on FDA approving a health claim for soy protein and the reduced risk of coronary heart disease for use with dietary supplements and food products. As the Rose Sheet today reports FDA's proposal to revoke the approval, we republish here the approval article from Oct. 25, 1999.

Soy Protein Health Claim For Reduced Heart Disease Clears FDA

Manufacturers may begin using a health claim for soy protein and the reduced risk of coronary heart disease (CHD) on food labeling immediately upon the expected publication of FDA's final rule in the Oct. 26 Federal Register.

Soy Protein Health Claim For Reduced Heart Disease Clears FDA

Manufacturers may begin using a health claim for soy protein and the reduced risk of coronary heart disease (CHD) on food labeling immediately upon the expected publication of FDA's final rule in the Oct. 26 Federal Register.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090234

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel